Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Goldman Sachs bets big on SKIMS with $225m funding, valuing shapewear empire at $5bn
Goldman Sachs bets big on SKIMS with $225m funding, valuing shapewear empire at $5bn Kim Kardashian’s apparel and shapewear brand SKIMS has completed a $225m equity financing round led by Goldman Sachs Alternatives, valuing the company at $5bn. The round also included...
KKR-backed Optiv enters private debt talks as $1bn maturity wall looms
KKR-backed Optiv enters private debt talks as $1bn maturity wall looms KKR-owned cybersecurity firm Optiv has entered private negotiations with some of its junior lenders as it faces a looming debt maturity wall next year, according to people familiar with the matter...
Permira set for $3bn Golden Goose exit as HongShan circles Italian luxury brand
Permira set for $3bn Golden Goose exit as HongShan circles Italian luxury brand Permira is in advanced talks to sell Italian luxury sneaker brand Golden Goose to HongShan Capital Group, in a deal expected to value the company at more than €2.5bn ($3bn), Reuters...